Ledipasvir Impurity 30 CAS CATO-C4X-331330
| CAS No. | CATO-C4X-331330 |
| Molecular Formula | C17H21NO2 |
| Molecular Weight | 271.35 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
CATO manufactures Ledipasvir Impurity 30 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
CATO supplies Ledipasvir Impurity 30 (CAS CATO-C4X-331330), a pharmacopoeial impurity reference standard (molecular formula C17H21NO2, MW 271.35 g/mol) used for the identification and quantification of trace impurities in APIs.
The molecular framework of Ledipasvir Impurity 30 (C17H21NO2) is characterized by a steroid core, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
Physical & Chemical Properties
| Molecular Formula | C17H21NO2 |
| Molecular Weight | 271.35 g/mol |
| Appearance | Pale yellow to yellow crystalline powder |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 8.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 1 |
Related Ledipasvir Standards
- Ledipasvir Impurity 29 (CAS CATO-C4X-331329)
- Ledipasvir Impurity 31 (CAS CATO-C4X-331331)
- Ledipasvir Impurity 32 (CAS CATO-C4X-331332)
- Ledipasvir Impurity 40 (CAS CATO-C4X-331340)
- Ledipasvir Impurity 8 (CAS CATO-C4X-33138)
- Ledipasvir Impurity 34 (CAS CATO-C4X-331334)
- Ledipasvir impurity 1 (CAS 134877-62-6)
- Ledipasvir Impurity 3 (CAS CATO-C4X-33133)
Recommended Standards
- Nefopam Impurity 3 (CAS 60725-36-2)
- Apalutamide Impurity 80 (CAS CATO-C4X-274980)
- Napropamide (CAS 15299-99-7)
- Gabapentin Impurity 10 (CAS 227626-60-0)
- Ceftazidime impurity 117 (CAS CATO-C4X-1212117)
- Citalopram Impurity 85 (CAS CATO-C4X-110985)
- Azilsartan Impurity N2 (CAS 1675221-59-6)
- 2',3'-Dihydro-1'H-spiro[cyclopentane-1,4'-isoquinoline]-1'-carboxylic acid (CAS 2173991-56-3)
- Methanone, (4-bromo-3-methylphenyl)-4-thiomorpholinyl- (CAS 1713436-27-1)
- 1-methyl-1H-1,2,3-triazole-4-carbonitrile (CAS 1142927-01-2)
- 3,3'-Diiodo-2,2'-dimethoxy-1,1'-binaphthalene (CAS 201206-92-0)
- 2-methyl-1H-1,3-benzodiazole-5-carbaldehyde (CAS 61587-91-5)
- 5-(trifluoromethyl)-2-pyridyl 6-chloropyridine-3-carbothioate (CAS 263707-25-1)
- Semaglutide impurity 47 (CAS CATO-C4X-222647)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com